Difficulty: Medium
Average Score: 88%
Practice
The mechanism of carbidopaÔÇ▓s action is:
Correct answer
B
Rationale
The correct answer is B) Inhibition of dopa decarboxylase. Carbidopa is a medication commonly used in combination with levodopa to treat Parkinson's disease. Dopa decarboxylase is an enzyme that converts levodopa to dopamine peripherally, leading to reduced effectiveness of levodduopa therapy due to dopamine being unable to cross the blood-brain barrier. By inhibiting dopa decarboxylase, carbidopa prevents this conversion in the peripheral tissues, allowing more levodopa to reach the brain and be converted to dopamine, thereby improving symptoms of Parkinson's disease.
Option A) Stimulating the synthesis, release, or reuptake of dopamine is incorrect because carbidopa does not directly affect the synthesis, release, or reuptake of dopamine.
Option C) Stimulating dopamine receptors is incorrect because carbidopa does not directly act on dopamine receptors.
Option D) Selective inhibition of catechol-O-methyltransferase (COMT) is incorrect because carbidopa does not selectively inhibit COMT. Instead, it primarily inhibits dopa decarboxylase.
In an educational context, understanding the mechanism of action of carbidopa is crucial for healthcare professionals, especially those working with patients with Parkinson's disease. Knowing how carbidopa works in combination with levodopa helps in optimizing treatment regimens, managing side effects, and improving patient outcomes. This knowledge also highlights the importance of combination therapies in managing complex conditions like Parkinson's disease.
Option A) Stimulating the synthesis, release, or reuptake of dopamine is incorrect because carbidopa does not directly affect the synthesis, release, or reuptake of dopamine.
Option C) Stimulating dopamine receptors is incorrect because carbidopa does not directly act on dopamine receptors.
Option D) Selective inhibition of catechol-O-methyltransferase (COMT) is incorrect because carbidopa does not selectively inhibit COMT. Instead, it primarily inhibits dopa decarboxylase.
In an educational context, understanding the mechanism of action of carbidopa is crucial for healthcare professionals, especially those working with patients with Parkinson's disease. Knowing how carbidopa works in combination with levodopa helps in optimizing treatment regimens, managing side effects, and improving patient outcomes. This knowledge also highlights the importance of combination therapies in managing complex conditions like Parkinson's disease.